ORIL 007
Alternative Names: ORIL-007Latest Information Update: 03 Nov 2022
At a glance
- Originator Oncology Research International
- Class Antineoplastics; Cyclohexanes; Glycosides; Polycyclic compounds; Small molecules; Steroid sapogenins
- Mechanism of Action Apoptosis stimulants; Cell membrane inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 22 Aug 2022 Preclinical trials in Cancer in Australia (PO)